Literature DB >> 20421518

Agreement is poor among current criteria used to define response to cardiac resynchronization therapy.

Brandon K Fornwalt1, William W Sprague, Patrick BeDell, Jonathan D Suever, Bart Gerritse, John D Merlino, Derek A Fyfe, Angel R León, John N Oshinski.   

Abstract

BACKGROUND: Numerous criteria believed to define a positive response to cardiac resynchronization therapy have been used in the literature. No study has investigated agreement among these response criteria. We hypothesized that the agreement among the various response criteria would be poor. METHODS AND
RESULTS: A literature search was conducted with the keywords "cardiac resynchronization" and "response." The 50 publications with the most citations were reviewed. After the exclusion of editorials and reviews, 17 different primary response criteria were identified from 26 relevant articles. The agreement among 15 of these 17 response criteria was assessed in 426 patients from the Predictors of Response to Cardiac Resynchronization Therapy (PROSPECT) study with Cohen's kappa-coefficient (2 response criteria were not calculable from PROSPECT data). The overall response rate ranged from 32% to 91% for the 15 response criteria. Ninety-nine percent of patients showed a positive response according to at least 1 of the 15 criteria, whereas 94% were classified as a nonresponder by at least 1 criterion. kappa-Values were calculated for all 105 possible comparisons among the 15 response criteria and classified into standard ranges: Poor agreement (kappa< or =0.4), moderate agreement (0.4<kappa<0.75), and strong agreement (kappa> or =0.75). Seventy-five percent of the comparisons showed poor agreement, 21% showed moderate agreement, and only 4% showed strong agreement.
CONCLUSIONS: The 26 most-cited publications on predicting response to cardiac resynchronization therapy define response using 17 different criteria. Agreement between different methods to define response to cardiac resynchronization therapy is poor 75% of the time and strong only 4% of the time, which severely limits the ability to generalize results over multiple studies.

Entities:  

Mesh:

Year:  2010        PMID: 20421518      PMCID: PMC2882855          DOI: 10.1161/CIRCULATIONAHA.109.910778

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  31 in total

1.  Utility of echocardiographic radial strain imaging to quantify left ventricular dyssynchrony and predict acute response to cardiac resynchronization therapy.

Authors:  Kaoru Dohi; Matthew S Suffoletto; David Schwartzman; Leonard Ganz; Michael R Pinsky; John Gorcsan
Journal:  Am J Cardiol       Date:  2005-07-01       Impact factor: 2.778

2.  Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase].

Authors:  John G F Cleland; Jean-Claude Daubert; Erland Erdmann; Nick Freemantle; Daniel Gras; Lukas Kappenberger; Luigi Tavazzi
Journal:  Eur Heart J       Date:  2006-06-16       Impact factor: 29.983

3.  Clinical versus echocardiographic parameters to assess response to cardiac resynchronization therapy.

Authors:  Gabe B Bleeker; Jeroen J Bax; Jeffrey Wing-Hong Fung; Ernst E van der Wall; Qing Zhang; Martin J Schalij; Joseph Yat-Sun Chan; Cheuk-Man Yu
Journal:  Am J Cardiol       Date:  2005-11-28       Impact factor: 2.778

4.  Tissue Doppler velocity is superior to displacement and strain mapping in predicting left ventricular reverse remodelling response after cardiac resynchronisation therapy.

Authors:  C-M Yu; Q Zhang; Y-S Chan; C-K Chan; G W K Yip; L C C Kum; E B Wu; P-W Lee; Y-Y Lam; S Chan; J W-H Fung
Journal:  Heart       Date:  2006-04-18       Impact factor: 5.994

5.  Septal to posterior wall motion delay fails to predict reverse remodeling or clinical improvement in patients undergoing cardiac resynchronization therapy.

Authors:  Gregory M Marcus; Emily Rose; Esperanza M Viloria; Jill Schafer; Teresa De Marco; Leslie A Saxon; Elyse Foster
Journal:  J Am Coll Cardiol       Date:  2005-12-20       Impact factor: 24.094

6.  Clinical and electrocardiographic predictors of a positive response to cardiac resynchronization therapy in advanced heart failure.

Authors:  Guillaume Lecoq; Christophe Leclercq; Emmanuelle Leray; Christophe Crocq; Christine Alonso; Christian de Place; Philippe Mabo; Claude Daubert
Journal:  Eur Heart J       Date:  2005-02-23       Impact factor: 29.983

7.  Predictors of lack of response to resynchronization therapy.

Authors:  Ernesto Díaz-Infante; Lluís Mont; Juan Leal; Ignacio García-Bolao; Ignacio Fernández-Lozano; Antonio Hernández-Madrid; Nicasio Pérez-Castellano; Marta Sitges; Ricardo Pavón-Jiménez; Joaquín Barba; Miguel A Cavero; José L Moya; Leopoldo Pérez-Isla; Josep Brugada
Journal:  Am J Cardiol       Date:  2005-06-15       Impact factor: 2.778

8.  Comparison of response to cardiac resynchronization therapy in patients with sinus rhythm versus chronic atrial fibrillation.

Authors:  Sander G Molhoek; Jeroen J Bax; Gabe B Bleeker; Eric Boersma; L van Erven; Paul Steendijk; Ernst E van der Wall; Martin J Schalij
Journal:  Am J Cardiol       Date:  2004-12-15       Impact factor: 2.778

9.  Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy.

Authors:  Gabe B Bleeker; Theodorus A M Kaandorp; Hildo J Lamb; Eric Boersma; Paul Steendijk; Albert de Roos; Ernst E van der Wall; Martin J Schalij; Jeroen J Bax
Journal:  Circulation       Date:  2006-02-13       Impact factor: 29.690

10.  Novel speckle-tracking radial strain from routine black-and-white echocardiographic images to quantify dyssynchrony and predict response to cardiac resynchronization therapy.

Authors:  Matthew S Suffoletto; Kaoru Dohi; Maxime Cannesson; Samir Saba; John Gorcsan
Journal:  Circulation       Date:  2006-02-13       Impact factor: 29.690

View more
  63 in total

1.  Increasing knowledge and changing views in cardiac resynchronization therapy.

Authors:  Laszlo Buga; John G F Cleland
Journal:  Heart Fail Rev       Date:  2012-11       Impact factor: 4.214

Review 2.  Current and future role of cardiovascular magnetic resonance in cardiac resynchronization therapy.

Authors:  Francisco Leyva; Paul W X Foley
Journal:  Heart Fail Rev       Date:  2011-05       Impact factor: 4.214

Review 3.  Targeting left ventricular lead placement to improve cardiac resynchronization therapy outcomes.

Authors:  Jeffrey Liu; Evan Adelstein; Samir Saba
Journal:  Curr Cardiol Rep       Date:  2013-08       Impact factor: 2.931

4.  Left ventricular mechanical dyssynchrony by phase analysis as a prognostic indicator in heart failure.

Authors:  Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2014-02       Impact factor: 5.952

5.  Myocardial motion and deformation patterns in an experimental swine model of acute LBBB/CRT and chronic infarct.

Authors:  Nicolas Duchateau; Marta Sitges; Adelina Doltra; Juan Fernández-Armenta; Nuria Solanes; Montserrat Rigol; Luigi Gabrielli; Etelvino Silva; Aina Barceló; Antonio Berruezo; Lluís Mont; Josep Brugada; Bart Bijnens
Journal:  Int J Cardiovasc Imaging       Date:  2014-03-21       Impact factor: 2.357

Review 6.  Cardiac resynchronization therapy: the issue of non-response.

Authors:  Luigi Padeletti; Alessandro Paoletti Perini; Edoardo Gronda
Journal:  Heart Fail Rev       Date:  2012-01       Impact factor: 4.214

Review 7.  [Cardiac resynchronisation therapy : new data and technical developments].

Authors:  C Butter
Journal:  Herz       Date:  2011-10       Impact factor: 1.443

Review 8.  Novel Pacing Strategies for Heart Failure Management.

Authors:  Jordan S Leyton-Mange; Theofanie Mela
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-08

9.  Inflammatory activation following interruption of long-term cardiac resynchronization therapy.

Authors:  Andrzej Rubaj; Piotr Ruciński; Krzysztof Oleszczak; Michał K Trojnar; Maciej Wójcik; Andrzej Wysokiński; Andrzej Kutarski
Journal:  Heart Vessels       Date:  2012-12-16       Impact factor: 2.037

Review 10.  Cardiac resynchronization therapy guided by cardiovascular magnetic resonance.

Authors:  Francisco Leyva
Journal:  J Cardiovasc Magn Reson       Date:  2010-11-09       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.